20 May 2016 09:20
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES |
 |  | |||
1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: | Immunodiagnostic Systems Holdings Plc | |||
2 Reason for the notification (please tick the appropriate box or boxes): | ||||
An acquisition or disposal of voting rights | X | |||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | Â | |||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | Â | |||
An event changing the breakdown of voting rights | Â | |||
Other (please specify): | Â | Â | ||
3. Full name of person(s) subject to thenotification obligation: | Shareholder Value Beteiligungen AG | |||
4. Full name of shareholder(s)Â (if different from 3.): | Â | |||
5. Date of the transaction and date onwhich the threshold is crossed orreached: | May 18th, 2016 | |||
6. Date on which issuer notified: | May 18th, 2016 | |||
7. Threshold(s) that is/are crossed orreached: | Crossing above 5% | |||
 |  |  |  |  |
Â
8. Notified details: | ||||||||||||||||
A: Voting rights attached to shares | ||||||||||||||||
Class/type ofshares if possible usingthe ISIN CODE | Situation previousto the triggeringtransaction | Resulting situation after the triggering transaction | ||||||||||||||
NumberofShares | NumberofVotingRights | Numberof shares | Number of votingrights | % of voting rights | ||||||||||||
Direct | Direct | Indirect | Direct | Indirect | ||||||||||||
Common Stock GB00B01YZ052 | 1,145,000 | 1,145,000 | 1,645,000 | 1,645,000 | Â | 5.59% | Â | |||||||||
 | ||||||||||||||||
 | ||||||||||||||||
B: Qualifying Financial Instruments | ||||||||||||||||
Resulting situation after the triggering transaction | ||||||||||||||||
Type of financialinstrument | Expirationdate | Exercise/Conversion Period | Number of votingrights that may beacquired if theinstrument isexercised/ converted. | % of votingrights | ||||||||||||
  N/A |  |  |  |  | ||||||||||||
 | ||||||||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments | ||||||||||||||||
Resulting situation after the triggering transaction | ||||||||||||||||
Type of financialinstrument | Exercise price | Expiration date | Exercise/Conversion period | Number of voting rights instrument refers to  | % of voting rights  | |||||||||||
  N/A |  |  |  |  | Nominal | Delta | ||||||||||
 |  | |||||||||||||||
 | ||||||||||||||||
Total (A+B+C) | ||||||||||||||||
Number of voting rights | Percentage of voting rights | |||||||||||||||
1,645,000 | 5.59% | |||||||||||||||
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Â
9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: | ||
 Shareholder Value Beteiligungen AG holds these shares directly  | ||
 | ||
Proxy Voting: | ||
10. Name of the proxy holder: | Â | |
11. Number of voting rights proxy holder will ceaseto hold: | Â | |
12. Date on which proxy holder will cease to holdvoting rights: | Â | |
 | ||
13. Additional information: | Â | |
14. Contact name: | Reiner Sachs | |
15. Contact telephone number: | + 49 69 66 98 30 11 | |
 |  |  |
Â
Â